Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.
Ueno Y, Enomoto T, Otsuki Y, Sugita N, Nakashima R, Yoshino K, Kuragaki C, Ueda Y, Aki T, Ikegami H, Yamazaki M, Ito K, Nagamatsu M, Nishizaki T, Asada M, Kameda T, Wakimoto A, Mizutani T, Yamada T, Murata Y.
Ueno Y, et al. Among authors: mizutani t.
Cancer Lett. 2006 Sep 28;241(2):289-300. doi: 10.1016/j.canlet.2005.10.035. Epub 2006 Feb 3.
Cancer Lett. 2006.
PMID: 16459017